Get Sample Pages - Cancer Informatics Market Trends and Demand Forecast, 2026

Global Cancer Informatics Market Research Report: Forecast (2021-2026)

By Product (Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support System (CDSS), Drug Discovery and Development Informatics (DDDI)), By Ap......plication (Medical Application, Surgical Application, Radiation Application), By Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other), By End-Users (Life Science industry, Academic Institutes and Research Centers, Pharmaceutical Companies, Contract Research Organizations (CROs), Others (Hospitals and Other Care Facilities)), By Region (North America, South America, Europe, Asia-Pacific, Middle East and Africa), By Country (US, Canada, Mexico, Brazil, UK, Italy, Germany, France, Russia, Spain, Saudi-Arabia, South-Africa, China, India, Japan, South-Korea, Australia), By Competitors (Elekta ab, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Hologic Inc., F.Hoffmann-La Roche Ltd., McKesson Corporation) Read more

Healthcare
Apr 2021
Pages 203
Report Format: PDF, Excel, PPT

Market Overview

Cancer Informatics is a comprehensive information solution that explores the crucial technologies, informatics trends of applying computational biology to cancer research and care. In Cancer Informatics, computer & information science and healthcare interconnect to acquire, store and use information regarding cancer thoroughly & efficiently.

According to the MarkNtel Advisors' research report, "Global Cancer Informatics Market Analysis, 2021," the market is likely to grow at a CAGR of around 7.5% during 2021-26. The growth of the cancer informatics market attributes to the rising prevalence of cancer, surging costs of cancer treatment, and mounting focus on reducing medical errors & readmission rates. However, the high costs involved while installing these solutions are amongst the most prominent challenges for the market.

Report Coverage	Details
Study Period	Historical Data: 2016-19
	Base Year: 2020
	Forecast Period: 2021-26
CAGR	7.5%
Regions Covered	North America: USA, Canada
	Europe: Germany, The UK, France, Spain, Italy and Others
	Asia-Pacific: China, India, Japan, South Korea, Australia and Others
	South America: Brazil, Mexico
	Middle East & Africa: Saudi Arabia, South Africa, Rest of the Middle East & Africa
Key Companies Profiled	Elekta ab, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Hologic Inc., F.Hoffmann-La Roche Ltd., McKesson Corporation
Unit Denominations	USD Million/Billion

Introduction
1. Product Definition
2. Research Process
3. Market Segmentation
4. Assumptions
Preface
Executive Summary
Impact of COVID-19 on Global Cancer Informatics Market
Global Cancer Informatics Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Global Cancer Informatics Market Policies and Product Standards
Global Cancer Informatics Market Trends & Insights
Global Cancer Informatics Market Hotspot & Opportunities
Global Cancer Informatics Market Key Strategic Imperatives for Success & Growth
Global Cancer Informatics Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Product
    1. Electronic Health Records (EHRs)
    2. Population Health Management (PHM)
    3. Clinical Decision Support System (CDSS)
    4. Drug Discovery and Development Informatics (DDDI)
  2. By Application
    1. Medical Application
    2. Surgical Application
    3. Radiation Application
  3. By Cancer Type
    1. Breast Cancer
    2. Prostate Cancer
    3. Colorectal Cancer
    4. Cervical Cancer
    5. Other
  4. By End-Users
    1. Life Science industry
    2. Academic Institutes and Research Centers
    3. Pharmaceutical Companies
    4. Contract Research Organizations (CROs)
    5. Others (Hospitals and Other Care Facilities)
  5. By Region
    1. North America
    2. Latin America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  6. By Company
    1. Competition Characteristics
    2. Market Share & Analysis
    3. Competitive Matrix
North America Cancer Informatics Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Product
  2. By Application
  3. By Cancer Type
  4. By End-Users
  5. By Country
    1. The US
    2. Canada
3. The US Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
4. Canada Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
Latin America Cancer Informatics Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Product
  2. By Application
  3. By Cancer Type
  4. By End-Users
  5. By Country
    1. Brazil
    2. Mexico
    3. Others
3. Brazil Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
4. Mexico Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
Europe Cancer Informatics Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Product
  2. By Application
  3. By Cancer Type
  4. By End-Users
  5. By Country
    1. The UK
    2. Italy
    3. Germany
    4. France
    5. Spain
    6. Russia
3. The UK Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
4. Italy Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
5. Germany Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
6. France Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
7. Spain Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
8. Russia Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
Middle East & Africa Cancer Informatics Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Product
  2. By Application
  3. By Cancer Type
  4. By End-Users
  5. By Country
    1. Saudi Arabia
    2. South Africa
    3. Rest of the Middle East & Africa
3. Saudi Arabia Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
4. South Africa Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
Asia-Pacific Cancer Informatics Market Outlook, 2016-2026F
1. Market Size & Analysis
2. Revenues
3. Market Share & Analysis
  1. By Product
  2. By Application
  3. By Cancer Type
  4. By End-Users
  5. By Country
    1. China
    2. Japan
    3. India
    4. South Korea
    5. Australia
    6. Others
4. China Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
5. Japan Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
6. India Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
7. South Korea Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
8. Australia Cancer Informatics Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product
    2. By Application
    3. By Cancer Type
    4. By End-Users
Competition Outlook
1. Competition Matrix
  1. Product/ Solution Portfolio
  2. Target Markets
  3. Target End Users
  4. Research & Development
  5. Strategic Alliances
  6. Strategic Initiatives
Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
1. Elekta ab
2. Varian Medical Systems
3. Accuray Incorporated
4. Cerner Corporation
5. RaySearch Laboratories
6. Flatiron
7. Oncology Analytics, Inc
8. Hologic Inc.
9. F.Hoffmann-La Roche Ltd.
10. McKesson Corporation
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *